X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.fda.gov/drugs/drug-safety-and-availability/fda-temporarily-exercising-enforcement-discretion-respect-certain-clozapine-rems-program#:~:text=On%20July%2029%2C%202021%2C%20FDA,able%20to%20prescribe%2Fdispense%20clozapine
https://www.pharmacist.com/Pharmacy-News/fda-puts-clozapine-rems-requirements-on-temporary-hold
https://www.fda.gov/drugs/drug-safety-and-availability/fda-temporarily-suspending-certain-clozapine-rems-program-requirements-ensure-continuity-care
https://www.fda.gov/drugs/drug-safety-and-availability/clozapine-risk-evaluation-and-mitigation-strategy-rems-requirements-will-change-november-15-2021
https://www.fda.gov/drugs/drug-safety-and-availability/clozapine-risk-evaluation-and-mitigation-strategy-rems-requirements-will-change-november-15-2021
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-1-2020-1593586904.pdf
https://www.fda.gov/drugs/drug-safety-and-availability/fda-strengthens-warning-untreated-constipation-caused-schizophrenia-medicine-clozapine-clozaril-can
https://www.fda.gov/safety/medical-product-safety-information/clozaril-fazaclo-odt-versacloz-clozapine-drug-safety-communication-fda-strengthens-warning-untreated
https://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm497790.htm?utm_campaign=FDA%20approves%20modification%20to%20the%20clozapine%20REMS%20-%20Drug%20Information%20Update&utm_medium=email&utm_source=Eloqua
https://www.raps.org/news-and-articles/news-articles/2019/1/fda-modifies-rems-program-for-clozapine?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2017%20January
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=910201811531
https://www.pharmacompass.com/pdf/news/pfizer-australia-issues-recall-of-clopine-suspension-clozapine-1536397636.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090308
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209775
https://www.biospectrumasia.com/news/25/9950/cadila-healthcares-arm-receives-final-approval-from-usfda-for-clozapine-tablets.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-gets-usfda-nod-for-schizophrenia-treatment-drug/articleshow/61977773.cms
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-6-2017-1512536772.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-17-2017-1494997195.pdf
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206433
http://www.bloomberg.com/news/articles/2016-11-11/saving-heroin-users-with-a-nasal-spray-is-an-80-million-business?
http://in.reuters.com/article/us-acadia-pharm-fda-idINKCN0XQ2L6
http://www.financialexpress.com/article/industry/companies/sun-pharma-psyco-remedies-settle-trademark-litigation/235254/
http://www.fiercepharma.com/story/chicago-psychiatrist-slapped-prison-time-teva-kickbacks-case/2016-03-17
http://www.prnewswire.com/news-releases/mylan-launches-generic-fazaclo-orally-disintegrating-tablets-300183629.html
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30
Market Place
Share 
